Covered recipient · General Payments record
ELEANOR WILKINSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$5,270.48
- Reported across 310 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $952.52 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $368.82 | 22 |
| PFIZER INC. | $142.22 | 10 |
| SK Life Science, Inc. | $84.10 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.96 | 2 |
| Lundbeck LLC | $41.92 | 2 |
| UCB, Inc. | $37.82 | 2 |
| Otsuka America Pharmaceutical, Inc. | $37.29 | 2 |
| Lilly USA, LLC | $32.65 | 2 |
| Teva Pharmaceuticals USA, Inc. | $29.58 | 2 |
| Averitas Pharma Inc. | $26.14 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $25.25 | 1 |
| Neurocrine BioSciences, Inc. | $24.61 | 1 |
| Neurelis, Inc. | $20.50 | 1 |
| Biogen, Inc. | $17.68 | 1 |
| Medtronic, Inc. | $16.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.14 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412371 | CMS |
| ABBVIE INC. | $10.16 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412373 | CMS |
| ABBVIE INC. | $11.98 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412375 | CMS |
| ABBVIE INC. | $3.78 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412377 | CMS |
| ABBVIE INC. | $7.12 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412379 | CMS |
| ABBVIE INC. | $16.75 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412381 | CMS |
| ABBVIE INC. | $18.59 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412383 | CMS |
| ABBVIE INC. | $11.52 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412385 | CMS |
| ABBVIE INC. | $5.03 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412387 | CMS |
| ABBVIE INC. | $7.49 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412389 | CMS |
| ABBVIE INC. | $28.28 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412391 | CMS |
| ABBVIE INC. | $7.33 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412393 | CMS |
| ABBVIE INC. | $73.81 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412395 | CMS |
| ABBVIE INC. | $26.98 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412397 | CMS |
| ABBVIE INC. | $2.88 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412399 | CMS |
| ABBVIE INC. | $28.80 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412401 | CMS |
| ABBVIE INC. | $11.01 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412403 | CMS |
| ABBVIE INC. | $14.45 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412405 | CMS |
| ABBVIE INC. | $29.36 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412407 | CMS |
| ABBVIE INC. | $7.90 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412409 | CMS |
| ABBVIE INC. | $16.28 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412411 | CMS |
| ABBVIE INC. | $12.18 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412413 | CMS |
| Averitas Pharma Inc. | $26.14 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133472043 | CMS |
| Biogen, Inc. | $17.68 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104874126 | CMS |
| Lilly USA, LLC | $14.33 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135626827 | CMS |
| Lilly USA, LLC | $18.32 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135550145 | CMS |
| Lundbeck LLC | $23.77 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146107043 | CMS |
| Lundbeck LLC | $18.15 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146107045 | CMS |
| Medtronic, Inc. | $16.98 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116998950 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $25.25 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144507848 | CMS |
| Neurelis, Inc. | $20.50 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145672324 | CMS |
| Neurocrine Biosciences, Inc. | $24.61 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150956760 | CMS |
| Novartis Pharmaceuticals Corporation | $26.79 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087425314 | CMS |
| Novartis Pharmaceuticals Corporation | $20.17 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087425316 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.96 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119213893 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.33 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119213895 | CMS |
| PFIZER INC. | $10.51 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131902005 | CMS |
| PFIZER INC. | $6.30 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131902003 | CMS |
| PFIZER INC. | $11.81 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131902007 | CMS |
| PFIZER INC. | $26.20 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131156431 | CMS |
| PFIZER INC. | $24.59 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131205717 | CMS |
| PFIZER INC. | $15.21 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131383958 | CMS |
| PFIZER INC. | $4.56 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131816802 | CMS |
| PFIZER INC. | $7.47 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131796144 | CMS |
| PFIZER INC. | $17.14 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131673802 | CMS |
| PFIZER INC. | $18.43 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131862283 | CMS |
| SK Life Science, Inc. | $30.16 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154113855 | CMS |
| SK Life Science, Inc. | $30.16 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154113877 | CMS |
| SK Life Science, Inc. | $23.78 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154113887 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.53 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151565379 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.05 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151565471 | CMS |
| UCB, Inc. | $16.37 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143304666 | CMS |
| UCB, Inc. | $21.45 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143304670 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.